Dr. Saumil Gandhi, MD
Claim this profileM D Anderson Cancer Center
Studies Lung Cancer
Studies Skin Cancer
9 reported clinical trials
19 drugs studied
Area of expertise
1Lung Cancer
Stage IV
EGFR positive
Stage III
2Skin Cancer
Stage IV
Stage III
Stage I
Affiliated Hospitals
M D Anderson Cancer Center
MD Anderson League City
Clinical Trials Saumil Gandhi, MD is currently running
Proton Therapy vs Photon Radiation
for Esophageal Cancer
This trial studies how well proton beam radiation therapy compared with intensity modulated photon radiotherapy works in treating patients with stage I-IVA esophageal cancer. Proton beam radiation therapy uses a beam of protons (rather than x-rays) to send radiation inside the body to the tumor without damaging much of the healthy tissue around it. Intensity modulated photon radiotherapy uses high-energy x-rays to deliver radiation directly to the tumor without damaging much of the healthy tissue around it. It is not yet known whether proton beam therapy or intensity modulated photon radiotherapy will work better in treating patients with esophageal cancer.
Recruiting2 awards Phase 31 criteria
NBTXR3 + Radiation Therapy
for Lung Cancer
This phase I trial investigates the best dose and side effects of NBTXR3 when given together with radiation therapy for the treatment of non-small cell lung cancer that cannot be treated by surgery (inoperable) and has come back (recurrent). NBTXR3 is a radio-enhancer designed to increase the radiotherapy energy dose deposition inside tumor cells. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving NBTXR3 and radiation therapy may increase radiation-dependent tumor cell killing without increasing the radiation exposure of healthy surrounding tissues.
Recruiting1 award Phase 112 criteria
More about Saumil Gandhi, MD
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Saumil Gandhi, MD has experience with
- Radiation Therapy
- NBTXR3
- Local Consolidation Therapy
- Pemetrexed Disodium
- Stereotactic MRI-guided Adaptive Radiotherapy-SMART
- Osimertinib
Breakdown of trials Saumil Gandhi, MD has run
Lung Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Saumil Gandhi, MD specialize in?
Saumil Gandhi, MD focuses on Lung Cancer and Skin Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are EGFR positive.
Is Saumil Gandhi, MD currently recruiting for clinical trials?
Yes, Saumil Gandhi, MD is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Saumil Gandhi, MD has studied deeply?
Yes, Saumil Gandhi, MD has studied treatments such as Radiation Therapy, NBTXR3, Local Consolidation Therapy.
What is the best way to schedule an appointment with Saumil Gandhi, MD?
Apply for one of the trials that Saumil Gandhi, MD is conducting.
What is the office address of Saumil Gandhi, MD?
The office of Saumil Gandhi, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.